Is the CyberKnife© radiosurgery system effective and safe for patients? An umbrella review of the evidence

Author:

Cheng Yifan12,Lin Yifei13ORCID,Long Youlin1,Du Liang1,Chen Rui4,Hu Tengyue5,Guo Qiong1,Liao Ga678,Huang Jin1ORCID

Affiliation:

1. Medical Device Regulatory Research & Evaluation Centre, West China Hospital, Sichuan University, Chengdu, PR China

2. Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, PR China

3. Precision Medicine Research Centre, West China Hospital, Sichuan University, Chengdu, PR China

4. School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, PR China

5. West China School of Medicine, Sichuan University, Chengdu, PR China

6. State Key Laboratory of Oral Diseases, National Clinical Research Centre for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, PR China

7. Medical Big Data Centre, Sichuan University, Chengdu, PR China

8. Department of Information Management, Department of Stomatology Informatics, West China Hospital of Stomatology, Sichuan University, Chengdu, PR China

Abstract

Background: The CyberKnife© system combines real-time image guidance and a dynamic tracking system to implement frameless radiotherapy. This umbrella review is aimed to evaluate the effectiveness and safety of CyberKnife. Methods: A comprehensive search of health technology assessments and systematic reviews was performed among the Embase, PubMed and other grey databases until July 2020. Treatment outcomes were extracted, and the quality of included studies were assessed using AMSTAR-2. Results: Nineteen studies were eligible. CyberKnife not only had a wide range of applications, long overall survival and great local control, but also had a limited toxicity and good cost–effectiveness compared with other radiotherapy equipment. Conclusion: Despite the relatively low quality of the evidence, our findings can still provide a decision reference for policymakers.

Funder

The National Key R & D Program of China

The Key Program of Sichuan Provincial Science and Technology Department, China

National Natural Science Foundation of China

The National Health Commission of the People's Republic of China

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Reference41 articles.

1. International Agency for Research on Cancer. World Cancer Report: Cancer Research for Cancer Prevention. Wild CP, Weiderpass E, Stewart BW (Eds). IARC Publications, Geneva, Switzerland (2020). www.iarc.who.int/cards_page/world-cancer-report/

2. Past, present, and future of radiotherapy for the benefit of patients

3. Robotics and More: New Technologies Emerge for Radiotherapy

4. The Cyberknife: A Frameless Robotic System for Radiosurgery

5. Innovative image-guided CyberKnife®stereotactic radiotherapy for bladder cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3